Yunnan Botanee Bio-Technology Group

Yunnan Botanee Bio-Technology Group (300957) Stock Price, Fundamentals & Analysis

StockShenzhen Stock ExchangeCSI 300Consumer Defensive

Price

32.94 CNY

-0.6%

Last trade: Sep 24, 2026, 03:04 PM GMT+8

Updated: Sep 27, 2026, 05:31 PM GMT+8

Price history

Over the past year 300957 traded between 30.17 CNY and 49.02 CNY, closing at 32.94 CNY on Sep 24, 2026.

Key statistics

Market cap13.95B CNY
P/E ratio (TTM)25.1
Forward P/E20.4
EPS (TTM)1.31 CNY
Dividend yield2.43%
Annual dividend0.8 CNY
Ex-dividend dateSep 22, 2026
Payout ratio50%
52-week range29.48 – 49.79
52-week change-27.1%
Beta0.55
Price / book2.24
Revenue (TTM)5.58B CNY
Revenue growth (YoY)3.6%
Gross margin72.9%
Operating margin15%
Profit margin9.9%
Return on equity8.9%
Debt / equity12.4
Volume6,065,955
Average volume7,513,372
ExchangeShenzhen

Profile

Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
3,574
Headquarters
Kunming, China

Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. It operates through Skin Care Products, Medical Instruments, and Makeup segments. The company offers face creams, toners, masks, serums, and lotions; and makeup products, including primers, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sale of skincare related medical devices and electronic beauty instruments comprising hyaluronic acid repair bio membranes and hyaluronic acid repair dressings used for the protection and care of skin barrier damage after minimally invasive surgery; provision of provision of supply chain management, warehouse services, capital market, and consulting services. In addition, the company offers home-use electronic radiofrequency beauty devices. Further, it offers Qiumei App, an AI system for common skin problems; and medical cosmetic centers that provide vocational training, organization operation, member management, activity planning, and advertising support under the Vvym brand name.

Overview

What 300957 does

Yunnan Botanee Bio-Technology Group (300957) is a stock listed on the Shenzhen Stock Exchange in the Consumer Defensive sector, specifically within the Household & Personal Products industry. Headquartered in Kunming, China, the company researches, develops, produces, and sells cosmetics in China and internationally. It operates through three segments: Skin Care Products, Medical Instruments, and Makeup. Its product range includes face creams, toners, masks, serums, lotions, and makeup items such as primers, powders, BB creams, and makeup removers. The company is also involved in skincare-related medical devices and electronic beauty instruments, including hyaluronic acid repair bio membranes and dressings for post-surgery skin barrier protection, as well as home-use radiofrequency beauty devices. It offers the Qiumei App, an AI system for common skin problems, and operates medical cosmetic centers under the Vvym brand.

Key numbers explained

  • The current price is 32.94 CNY, reflecting the latest trading value of one share.
  • The trailing P/E ratio of 25.1 shows how much investors pay per unit of recent earnings; a higher number can indicate higher growth expectations or a richer valuation.
  • The forward P/E ratio of 20.4 uses expected future earnings, offering a view of valuation based on what analysts anticipate.
  • The dividend yield of 2.43% represents the annual dividend payment as a percentage of the current share price, indicating the cash return shareholders receive.
  • The beta of 0.55 suggests the stock tends to be less volatile than the overall market, moving about half as much in percentage terms.
  • The price-to-book ratio of 2.24 compares the market price to the company's book value per share, a common measure of whether the market values the company above its accounting net assets.
  • The return on equity of 8.9% measures how effectively the company generates profit from shareholders' equity.
  • The debt-to-equity ratio of 12.4% indicates a relatively low level of debt compared to equity, pointing to a conservative capital structure.

What to watch

As a Consumer Defensive stock, Yunnan Botanee Bio-Technology Group (300957) is often influenced by consumer spending trends and demand for personal care products. Investors typically monitor raw material costs, competitive dynamics in the cosmetics and beauty device markets, and regulatory changes affecting skincare and medical cosmetic devices. The company's exposure to both domestic and international markets means currency fluctuations and trade conditions can also be relevant factors. For broader context, it is part of the Shenzhen Stock Exchange ecosystem, which includes peers such as Wuliangye Yibin (000858) and Luzhou Lao Jiao (000568).

Latest news & filings

No recent headlines.

Frequently asked questions

Does 300957 pay a dividend?

Yes, it has a dividend yield of 2.43%, with 50% of earnings paid out as dividends. The next ex-dividend date is Sep 22, 2026.

What is the 300957 P/E ratio?

The trailing P/E ratio is 25.1, and the forward P/E ratio based on expected earnings is 20.4.

Where can I buy 300957?

It is listed on the Shenzhen Stock Exchange, so you can buy it through any broker that provides access to that market.

How big is Yunnan Botanee Bio-Technology Group?

It has a market capitalization of 13.95 billion CNY and employs 3,574 people.

How volatile is 300957 compared to the market?

Its beta is 0.55, indicating it is less volatile than the broader market.

What is the 52-week price range for 300957?

The lowest price in the last 52 weeks was 29.48 CNY, and the highest was 49.79 CNY.

Track 300957 in your portfolio

Hold 300957 at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.

Start free

Data updated Sep 27, 2026, 05:31 PM GMT+8. Sources: Yahoo Finance, Bucharest Stock Exchange.

For information and education only — not investment advice. Prices may be delayed. The overview is generated with AI from the data shown on this page.